Please login to the form below
ABPI
This page shows the latest ABPI news and features for those working in and with pharma, biotech and healthcare.
NHS and pharmaceutical industry partnerships to change millions of lives
In addition, the ABPI has also published a library of more than 100 successful NHS-industry partnerships. ... In addition, the ABPI’s library of case studies was published as evidence of successful partnerships to stimulate further cross-sector
Latest news
-
UK government and NIHR accelerate plans to improve clinical research delivery
The government’s response follows an annual report published by the Association of the British Pharmaceutical Industry (ABPI), showing improvements in the UK’s clinical trial sector. ... the ABPI has recommended the government continue to prioritise
-
UK’s Autumn Budget details measures to boost life sciences sector
The Association of the British Pharmaceutical Industry (ABPI) has welcomed the measures, with ABPI chief executive Richard Torbett saying that Hunt has “recognised the high potential of UK life sciences to
-
Landmark UK medicines deal to save NHS £14bn in medicine costs
The UK government, NHS England and the Association of the British Pharmaceutical Industry (ABPI) have agreed to a landmark deal that is set to save the NHS £14bn in medicine costs ... Richard Torbett, chief executive, ABPI, said: “Allowing the sector
-
ABPI report shows improvement in UK industry clinical trial performance
The Association of the British Pharmaceutical Industry’s (ABPI) annual report has shown signs of improvements in the UK’s clinical trial sector. ... The ABPI called on the government to ensure sustainable long-term recovery in UK clinical trial
-
UK antibiotic subscription model found by OHE as key to supporting investment
Paul Catchpole, director, value and access policy at the Association of the British Pharmaceutical Industry (ABPI), said: “By establishing a permanent subscription framework for antimicrobial products, the UK is setting an
More from news
Approximately 102 fully matching, plus 523 partially matching documents found.
Latest Intelligence
-
Maintaining continuity of care in Ukraine as conflict continues
The Association of the British Pharmaceutical Industry (ABPI) has detailed the response of its member companies offering humanitarian support both in Ukraine and for the emerging refugee crisis in neighbouring countries.
-
Looking to the future of patient empowerment
system of collecting data on information relating to drug products (ABPI, 2018).
-
Transforming clinical trials to accelerate drug development
While the Association for British Pharmaceutical Industries (ABPI’s) latest report indicates that the UK retains its position as Europe’s leading location for early phase studies, the overall number of
-
Collaboration over complacency in reshaping the future of cardiovascular care
This article is sponsored by Daiichi Sankyo Europe and has been reviewed to ensure compliance with the ABPI code of practice.
-
Paving the way for representation in clinical trials
workplace. Beyond Janssen, during my time as Chair of ABPI Wales 2019–2021, our DE&I focus included sponsoring the Womenspire Woman in STEM award and the work of Chwarae Teg,
More from intelligence
Approximately 8 fully matching, plus 55 partially matching documents found.
Latest appointments
-
Doina Ionescu elected to ABPI’s board of directors
The Association of the British Pharmaceutical Industry (ABPI) has elected Doina Ionescu, managing director and general manager for Merck Healthcare UK and Ireland, to its board of directors. ... I feel privileged and delighted to have been elected onto
-
Syneos Health Communications announces senior hires to Europe-based team
She has previously led global campaigns for the World Health Organisation, The Global Fund, IFPMA, The Bill and Melinda Gates Foundation and the ABPI.
-
Roudie Shafie joins OVID Health’s senior team as director
Shafie's previous experience includes roles at the ABPI and Pfizer UK. ... Shafie’s career experience includes time spent as head of government affairs at the ABPI and corporate public affairs lead for Pfizer UK.
-
Neurocentrx appoints two members to the board
His career history has seen him work in private equity and venture capital and he has been president of the ABPI.
-
Professor Carole Longson moves from NICE to the ABPI
Longson brings research, academic and pharmaceutical industry experience to the ABPI, including seven years as a research lead at GlaxoSmithKline. ... experience, expertise and network in both industry and academia will enable the ABPI to work with our
More from appointments
Approximately 21 fully matching, plus 15 partially matching documents found.
Latest from PMHub
-
The speed of science and the pace of comms
and often for good reason, as we saw during the eye-opening presentation from Dr Rina Newton, ABPI Code and Compliance expert, on navigating regulation frameworks.
-
Kate Shaw comments the appointment of an independent review on clinical trials in the UK.
The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five years.
-
Innovative Trials on the latest ABPI report
Kate Shaw, Innovative Trials Founder &CEO, commented on the latest ABPI report. ... The latest The Association of the British Pharmaceutical Industry (ABPI) report highlights " that patient access to industry studies on the National Institute for
-
The role of pharma in breaking through the backlog
An ABPI survey of more than 8000 people showed that public appreciated what pharma did during the worst of Covid, and the reputation of the industry has improved as a result.
-
Key barriers to effective patient engagement in pharma, and how to fix them: Making engagement processes more patient friendly
This year’s ABPI Code of Practice was also positioned to support collaborative working. ... More progress may be needed, but the ABPI are actively working on this and will want input from the pharma industry to ensure it works for both sides.
More from PMHub
Approximately 3 fully matching, plus 31 partially matching documents found.
Subscribe to our email news alerts
- Roche to acquire Carmot Therapeutics in deal worth up to $3.1bn
- Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas
- UK-India research project trialling easy-to-use UTI test to support fight against AMR
- Cancer Research UK and Guardant collaborate to advance cancer detection and treatment
- Give the gift of positive change
- Apple Vision Pro: challenges and opportunities for pharma
No results were found
PMHub
Wave Healthcare Communications
Wave combine scientific, medical and brand expertise to deliver clinically focused programmes that are trusted by HCPs, drive better patient...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
